Acting US FDA commissioner, Janet Woodcock, has called for an independent federal review of interactions between officials at her agency and representatives of Biogen, prior to the recent approval of the pharma company’s treatment for Alzheimer’s disease....
The multi-stakeholder group is developing a blockchain-powered platform to increase transparency and collaboration in the clinical trial supply chain – and has successfully completed a proof-of-concept project, now looking to next steps.
US contract manufacturer Catalent Pharma Solutions has leveraged
its partnership with Secure Symbology (SSI) for track and trace
barcode technology to help biopharmaceutical company Biogen Idec
comply with California's pending...
With a number of companies competing in the race to develop the
first oral treatment option for multiple sclerosis, UCB and Biogen
Idec's oral version of the infamous Tysabri has entered Phase II
Biogen has revealed details of a potential new pathway in
rheumatoid arthritis (RA) that could provide unique insights into
the disease process and eventually a new approach to developing RA
Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...